Pradaxa
These highlights do not include all the information needed to use PRADAXA Oral Pellets safely and effectively. See full prescribing information for PRADAXA Oral Pellets. PRADAXA (dabigatran etexilate) oral pellets Initial U.S. Approval: 2010
9ac0a64a-8666-45f7-9d4f-40fd894f7e6d
HUMAN PRESCRIPTION DRUG LABEL
Nov 27, 2023
Boehringer Ingelheim Pharmaceuticals, Inc.
DUNS: 603175944
Products 6
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
dabigatran etexilate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (7)
dabigatran etexilate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (7)
dabigatran etexilate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (7)
dabigatran etexilate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (7)
dabigatran etexilate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (7)
dabigatran etexilate
Product Details
FDA regulatory identification and product classification information